Commitments and Contingencies (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended	9 Months Ended
	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2020
Loss Contingencies [Line Items]
Costs reimbursable from Novartis		$ 1,082	$ 1,082
Novartis Agreement [Member] | Bio Medical Research Inc [Member]
Loss Contingencies [Line Items]
Costs reimbursable from Novartis		$ 500	$ 1,100
Costs reimbursable from Novartis				$ 1,100
Aurigene Agreement [Member]
Loss Contingencies [Line Items]
Milestone payments to be paid to collaborative partner	$ 60,000
Upfront payment, research and development.	8,000
Aurigene Agreement [Member] | Commercial Milestone [Member]
Loss Contingencies [Line Items]
Milestone payments to be paid to collaborative partner	$ 370,000